Genesco Inc. — Fiscal 2024 Form 10-K
Business context and reporting period. Genesco is a footwear and accessories retailer and wholesaler operating Journeys, Schuh, Johnston & Murphy and Genesco Brands Group. The fiscal year ended February 3, 2024, included 53 weeks; Fiscal 2023 included 52 weeks. This filing reports annual results, not standalone fourth-quarter results. Unless noted, amounts are U.S. dollars.
Financial performance
| Metric | Fiscal 2024 | Fiscal 2023 |
|---|---|---|
| Net sales | $2.325 billion | $2.385 billion |
| Gross margin | $1.099 billion; 47.3% of sales | $1.136 billion; 47.6% |
| Operating income (loss) | ($13.5 million); (0.6%) margin | $93.2 million; 3.9% margin |
| Continuing-operations pretax income (loss) | ($21.8 million) | $90.1 million |
| Net earnings (loss) | ($16.8 million); diluted EPS ($1.50) | $71.9 million; diluted EPS $5.66 |
| Cash from (used in) operating activities | $94.8 million | ($164.9 million) |
| Capital expenditures | $60.3 million | $59.9 million |
| Cash at year-end | $35.2 million | $48.0 million |
Sales declined 2.5% year over year, or 3.6% excluding the 53rd week. Comparable sales fell 4% overall: same-store sales declined 7%, while comparable direct sales increased 8%. Selling and administrative expense rose to 46.5% of sales from 43.7%, primarily reflecting expense deleverage as revenue weakened. Net interest expense increased to $7.8 million from $2.9 million, amid higher average borrowings and interest rates.
Segments
- Journeys: Sales fell 8.0% to $1.364 billion; operating income fell 88.3% to $11.1 million (0.8% margin). Management cited pressured discretionary spending, weaker store sales and promotional activity. The segment closed a net 67 stores.
- Schuh: Sales rose 11.1% to $480.2 million, including 8% growth in local currency; operating income rose 21.8% to $21.4 million (4.5% margin).
- Johnston & Murphy: Sales rose 7.8% to $339.4 million; operating income rose 13.6% to $16.3 million (4.8% margin). Retail and e-commerce growth partly offset lower wholesale sales.
- Genesco Brands Group: Sales fell 9.5% to $141.2 million; operating loss narrowed to approximately break-even from $0.7 million.
Liquidity, debt and capital
At February 3, 2024, cash was $35.2 million, current assets were $507.4 million and current liabilities were $319.5 million. Revolver debt was $34.7 million at a weighted-average rate of 7.79%; the main credit facility has $332.5 million in commitments, with $218.8 million of excess availability. Genesco reported compliance with relevant credit-facility terms. Schuh had no borrowings under its £19 million facility. Operating lease liabilities totaled $488.3 million; undiscounted contractual lease payments were $566.9 million.
Operating cash flow improved by $259.7 million year over year, principally due to inventory reductions, including a $263.9 million favorable change in inventory-related cash flow cited by management. Inventory on the balance sheet declined to $379.0 million from $458.0 million. Genesco repurchased 1.261 million shares for $32.0 million during Fiscal 2024; $52.1 million remained under its repurchase authorization. The company does not anticipate cash dividends in the foreseeable future.
Material changes, outlook and risks
- Genesco recorded a $28.5 million non-cash goodwill impairment, fully impairing goodwill associated with the Togast reporting unit in Genesco Brands Group. The filing identifies a licensor renewal dispute as an impairment indicator; the dispute was resolved in Fiscal 2025.
- Fiscal 2024 net loss included $9.4 million of insurance proceeds related to legacy environmental matters ($7.2 million net of tax), recorded in discontinued operations. The effective tax rate was negative 8.5%, primarily reflecting a valuation allowance against tax attributes the company no longer expects to realize.
- A $56.8 million non-current prepaid tax receivable relates to a federal tax refund claim under IRS audit. The company expects the examination to extend more than 12 months; the ultimate timing and amount remain subject to the audit.
- Management expects cash on hand, operating cash flow and available credit to meet Fiscal 2025 and foreseeable liquidity needs. It forecasts Fiscal 2025 capital expenditures of approximately $52–$57 million and plans about 14 store openings and 52 closures. The filing does not provide a clear sales or earnings forecast.
- Wholesale backlog was approximately $49.0 million as of March 2, 2024, down from $72.7 million a year earlier, primarily due to planned lower value-channel orders related to the Levi’s license. Genesco agreed not to exercise the four-year Levi’s renewal and instead extended the license under modified terms through at least February 2026; the Dockers license was expected to be renewed through 2027.
- Key risks include discretionary consumer demand, fashion and inventory-markdown exposure, mall traffic, competitive pressure, wage and occupancy costs, imported-product and shipping disruptions, foreign exchange, and reliance on licensors and third-party suppliers. Four wholesale customers represented 18%, 16%, 11% and 10% of trade receivables, respectively.
- Environmental proceedings relate to former facilities. The company accrued $2.0 million for environmental contingencies and stated it does not expect the identified site obligations to materially affect financial condition or results; actual outcomes remain uncertain.
Important facts for investors to verify
- Whether Journeys sales and margins stabilize after the sharp operating-income decline, and whether direct-sales growth offsets weaker store trends.
- How much of the operating-cash-flow improvement is sustainable versus attributable to inventory reductions and working-capital timing.
- The status, timing and recoverability of the $56.8 million IRS refund claim and related tax-attribute valuation allowance.
- Fiscal 2025 execution against store-closure, capital-spending and liquidity plans, including lease obligations and credit availability.
- The financial impact of the modified Levi’s license terms, lower wholesale backlog and the resolution of the licensor dispute.